GRANULES INDIA LTD.-$ - 532482 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report under Regulation 24A for the FY 2019-20.23-04-2020
23-04-2020
GRANULES INDIA LTD.-$ - 532482 - Sub: Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Of Regulations,2015.
Sub: Submission of Certificate under regulation 40(9) of SEBI (LODR) of Regulations,2015.21-04-2020
GRANULES INDIA LTD.-$ - 532482 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0990 Name of the Signatory :- CHAITANYA TUMMALADesignation :- Company Secretary and Compliance Officer21-04-2020
GRANULES INDIA LTD.-$ - 532482 - Shareholding for the Period Ended March 31, 2020
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here10-04-2020
Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine capsules
Granules India Ltd on Thursday said its foreign subsidiary has received approval from the US health regulator for Butalbital, Acetaminophen and Caffeine Capsules used to treat tension headaches.09-04-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited announces approval of Butalbital, Acetaminophen and Caffeine Capsules USP09-04-2020
GRANULES INDIA LTD.-$ - 532482 - Granules India'S Visakhapatnam Facility Received EU GMP Approval
Granules India's Visakhapatnam facility received EU GMP approval07-04-2020
GRANULES INDIA LTD.-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd04-04-2020